-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on MetLife, Lowers Price Target to $94

Benzinga·01/08/2026 18:38:20
Listen to the news
UBS analyst Brian Meredith maintains MetLife (NYSE:MET) with a Buy and lowers the price target from $95 to $94.